The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for ...

Clonell launches the world’s first patient-specific embryonic stem cell therapy platform, aimed at incurable diseases with ...

Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...

Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.

January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

Stem cells can fight disease from the inside out. But not all treatments are created equal. By Mohana Ravindranath The promise of stem cell therapy is powerful. Scientists can draw versatile cells ...

Very small embryonic-like stem cells (VSELs) are a rare and intriguing subpopulation of adult stem cells that exhibit molecular signatures reminiscent of embryonic stem cells. Identified in various ...